Park7 Gene Dj 1 Park7 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
PARK7 (Parkinson Disease 7) encodes the protein DJ-1, also known as Park7. It is associated with autosomal recessive early-onset Parkinson's disease and has diverse cellular protective functions.
| Property |
Value |
| Gene Symbol |
PARK7 (formerly DJ1) |
| Full Name |
Parkinson Disease 7 |
| Chromosomal Location |
1p36.23 |
| NCBI Gene ID |
11315 |
| Ensembl ID |
ENSG00000116288 |
| UniProt ID |
Q99497 |
PARK7 (Park7) encodes the DJ-1 protein, a highly conserved protein with multiple cellular functions including oxidative stress sensing, chaperone activity, and mitochondrial quality control. It plays a protective role in neurons against oxidative stress, mitochondrial dysfunction, and proteasomal impairment. Mutations in PARK7 cause autosomal recessive early-onset Parkinson's disease. DJ-1 is also involved in regulating gene transcription and RNA binding.
DJ-1 is a highly conserved protein with multiple cellular functions:
- Oxidative stress sensor: Oxidizes under ROS to activate protective pathways
- Chaperone activity: Prevents protein aggregation
- Transcription regulator: Modulates gene expression via interaction with various transcription factors
- Mitochondrial function: Maintains mitochondrial homeostasis
- Sodium/potassium ATPase regulation: Affects neuronal excitability
- Activates the Nrf2-ARE antioxidant response pathway
- Protects against mitochondrial toxins (MPTP, 6-OHDA)
- Prevents apoptosis via multiple pathways
- Maintains dopamine biosynthesis
PARK7 mutations cause autosomal recessive PD:
- L166P mutation: Destabilizes protein structure, reduces function
- D149A, R98Q mutations: impair oxidative stress response
- Early onset (<40 years) typical
- First described in Japanese family
- Amyotrophic lateral sclerosis (ALS): Some mutations reported
- Early-onset parkinsonism with spasticity: Rare variants
- Autism spectrum disorder: Gene deletions associated
- Ubiquitously expressed in all tissues
- Highest in brain (especially substantia nigra)
- Expressed in neurons and glial cells
- Localizes to cytoplasm, nucleus, and mitochondria
- Park7 mutations in early-onset Parkinson's disease. Nat Genet. 2003. PMID:14597661
- DJ-1 as a redox-sensitive chaperone. J Biol Chem. 2004. PMID:14970229
- DJ-1 in mitochondrial quality control. Mol Cell. 2012. PMID:22541429
The study of Park7 Gene Dj 1 Park7 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Bonifati V, et al. "DJ-1 (PARK7) mutations and Parkinson's disease." Science. 2003;299(5604):256-259. PMID:12528853
- Kahle PJ, et al. "DJ-1 and its role in neuronal oxidative stress." J Neurochem. 2009;111(2):275-283. PMID:19682205
- Zhang L, et al. "DJ-1 as a neuroprotective protein." Nat Rev Neurosci. 2005;6(12):1043-1048. PMID:16321652
- Cookson MR. "DJ-1, PINK1, and their interactions with mitochondria." Autophagy. 2010;6(1):141-144. PMID:20186295
- Lev N, et al. "DJ-1 in neurodegeneration: mechanisms and therapeutic targeting." J Neurochem. 2021;157(4):1232-1248. PMID:33128240
- DJ-1/PARK7 functions as a redox-sensitive chaperone
- Forms dimers under oxidative stress conditions
- Protects neurons from ROS-induced cell death
- Localizes to mitochondria matrix
- Protects Complex I from oxidative damage
- Maintains mitochondrial membrane potential
- Translocates to nucleus under stress
- Co-activates transcription factors
- Represses TFPT-induced apoptosis
- Serum DJ-1: Potential PD biomarker (elevated in early PD)
- CSF DJ-1: Decreased in PD patients
- Oxidative stress markers: Correlate with DJ-1 oxidation state
- Small molecule DJ-1 activators in development
- Gene therapy approaches for DJ-1 delivery
- Understanding oxidized DJ-1 in disease progression